ACG Announces Major Gift By Salix Pharmaceuticals, Inc.
PHILADELPHIA, Oct. 15 /PRNewswire-USNewswire/ — The American College of Gastroenterology and its Institute for Clinical Research & Education today announced a commitment of $1 million over four years by Salix Pharmaceuticals, Inc. The Salix pledge is an important milestone in the ACG’s Advancing Excellence campaign to provide long-term support for the Institute’s mission of innovative clinical research, patient education and gastroenterology practice excellence.
“This generous gift from one of our specialty’s innovative newcomers boosts an impressive fundraising effort that so far has resulted in more than $16 million to support clinical research, as well as patient and physician education. The College is proud of the unprecedented support for the Institute and its mission. We recognize the generosity and commitment of Salix’s leadership, including Carolyn Logan, President and CEO,” said ACG President Dr. David A. Johnson.
From the campaign’s beginning in 2002, the ACG Institute set an ambitious goal. From a position of burgeoning financial strength, the Institute has been able to achieve a significant boost in its support for patient-oriented research and to expand its educational programming.
About the American College of Gastroenterology
The ACG was formed in 1932 to advance the scientific study and medical treatment of disorders of the gastrointestinal (GI) tract. The College promotes the highest standards in medical education and is guided by its commitment to meeting the needs of clinical gastroenterology practitioners.
About the ACG Institute for Clinical Research & Education
The ACG Institute’s primary mission is to advance the field of clinical gastroenterology through education and research. Consistent with that mission, the ACG Institute for Clinical Research & Education serves as a forum in which to build on the goals of the College. The Institute promotes research in clinical gastroenterology, educates physicians and the public, and provides resources to support the future needs of clinical gastroenterology, GI patients, as well as young clinical investigators who as they develop careers in academic gastroenterology, enrich knowledge and treatments in digestive diseases.
Founded in 1994, the ACG Institute for Clinical Research & Education has emerged as a major source of funding for patient care oriented gastroenterology research, and an active and effective sponsor of educational programming for consumers and physicians alike.
About Salix
Salix Pharmaceuticals, Ltd., headquartered in Raleigh, North Carolina, develops and markets prescription pharmaceutical products for the treatment of gastrointestinal diseases. Salix’s strategy is to in-license late-stage or marketed proprietary therapeutic drugs, complete any required development and regulatory submission of these products, and market them through the Company’s 150-member gastroenterology specialty sales and marketing team.
American College of Gastroenterology
CONTACT: Anne-Louise Oliphant of ACG, +1-301-263-9000,mediaonly@acg.gi.org